Plasmid encoding papillomavirus Type 16 (HPV16) DNA constructed with codon optimization improved the immunogenicity against HPV infection
- 16 December 2004
- Vol. 23 (5) , 629-638
- https://doi.org/10.1016/j.vaccine.2004.07.010
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Enhanced immune response to DNA-based HPV16L1 vaccination by costimulatory molecule B7-2Antiviral Research, 2003
- Heterologous boosting increases immunogenicity of chimeric papillomavirus virus-like particle vaccinesVaccine, 2003
- Contributions in the domain of cancer research: Review¶Human papillomaviruses and their role in cervical cancerCellular and Molecular Life Sciences, 2001
- Enhancement of Capsid Gene Expression: Preparing the Human Papillomavirus Type 16 Major Structural Gene L1 for DNA Vaccination PurposesJournal of Virology, 2001
- Vaccine regimen for prevention of sexually transmitted infections with human papillomavirus type 16Vaccine, 2001
- Enhancement of Sindbis Virus Self-Replicating RNA Vaccine Potency by Linkage of Herpes Simplex Virus Type 1 VP22 Protein to AntigenJournal of Virology, 2001
- Genetic immunization: a new era in vaccines and immune therapeuticsThe FASEB Journal, 1997
- Chimeric Papillomavirus-like ParticlesVirology, 1997
- Human Papillomavirus Infection of the CervixObstetrics & Gynecology, 1992
- Association between poor prognosis in early-stage invasive cervical carcinomas and non-detection of HPV DNAThe Lancet, 1990